trending Market Intelligence /marketintelligence/en/news-insights/trending/DvaQTw4kHUzqHclt9u7Otw2 content esgSubNav
In This List

Blueprint Medicines closes $325.5M common stock offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Blueprint Medicines closes $325.5M common stock offering

Blueprint Medicines Corp. closed its public offering of common stock and raised about $325.5 million in net proceeds.

The company sold 4,259,259 common shares at $81.00 per share, which included the underwriters' full exercise of their option to buy additional shares.

Goldman Sachs & Co. LLC, Morgan Stanley and Cowen acted as joint book-running managers, while Canaccord Genuity acted as co-manager for the offering.